MOSCOW (Sputnik) – Those who are doubtful of Russia’s Sputnik V vaccine now have no more reasoning for criticism as the phase 3 trials have proved the vaccine’s efficacy, as evidenced by a publication in the Lancet medical journal, CEO of Russian Direct Investment Fund (RDIF) Kirill Dmitriev said on Tuesday.